Citation Impact
Citing Papers
Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study
2017 Standout
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
2016 Standout
The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins
2013 StandoutScienceNobel
Machine Learning-based Classification of Diffuse Large B-cell Lymphoma Patients by Their Protein Expression Profiles
2015
Human Inborn Errors of Immunity: 2019 Update on the Classification from the International Union of Immunological Societies Expert Committee
2020 Standout
Non-Cell-Autonomous Tumor Suppression by p53
2013
NF-κB signaling in inflammation
2017 Standout
The NF-κB regulator MALT1 determines the encephalitogenic potential of Th17 cells
2012
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
2019 Standout
AMPK: guardian of metabolism and mitochondrial homeostasis
2017 Standout
Structural Architecture of the CARMA1/Bcl10/MALT1 Signalosome: Nucleation-Induced Filamentous Assembly
2013
Mechanisms of hepatic stellate cell activation
2017 Standout
Nuclear factor kappa B (NF-κB) in multiple sclerosis pathology
2013
B-Cell Receptor Signaling in Diffuse Large B-Cell lymphoma
2015
The MaxQuant computational platform for mass spectrometry-based shotgun proteomics
2016 Standout
The dual role of neutrophils in cancer
2021
Understanding the tumor immune microenvironment (TIME) for effective therapy
2018 Standout
The biology and function of fibroblasts in cancer
2016 Standout
Lung tumor NF-κB signaling promotes T cell–mediated immune surveillance
2013
NFκBiz protein downregulation in acute kidney injury: Modulation of inflammation and survival in tubular cells
2016
Unified Polymerization Mechanism for the Assembly of ASC-Dependent Inflammasomes
2014 Standout
The complexity of NF-κB signaling in inflammation and cancer
2013 Standout
Cellular senescence in ageing: from mechanisms to therapeutic opportunities
2020 Standout
A UBE2O-AMPKα2 Axis that Promotes Tumor Initiation and Progression Offers Opportunities for Therapy
2017
The PI3K pathway in B cell metabolism
2016
IL-17 metabolically reprograms activated fibroblastic reticular cells for proliferation and survival
2019
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Crosstalk between Wnt/β-Catenin and NF-κB Signaling Pathway during Inflammation
2016
The CBM-opathies—A Rapidly Expanding Spectrum of Human Inborn Errors of Immunity Caused by Mutations in the CARD11-BCL10-MALT1 Complex
2018
The Perseus computational platform for comprehensive analysis of (prote)omics data
2016 Standout
The importance of antioxidants which play the role in cellular response against oxidative/nitrosative stress: current state
2015 Standout
SIRT1 Suppresses the Senescence-Associated Secretory Phenotype through Epigenetic Gene Regulation
2015
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Oxidative Stress in Cancer
2020 Standout
Diffuse large B-cell lymphoma—treatment approaches in the molecular era
2013
Hallmarks of Cellular Senescence
2018 Standout
Cellular senescence and its effector programs
2014
PTEN opposes negative selection and enables oncogenic transformation of pre-B cells
2016
The diverse and complex roles of NF-κB subunits in cancer
2012
Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms
2013 Standout
The PI3K Pathway in Human Disease
2017 Standout
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivity
2011
Targeting the CBM complex causes Treg cells to prime tumours for immune checkpoint therapy
2019 Nature
NF-κB Directly Regulates Fas Transcription to Modulate Fas-mediated Apoptosis and Tumor Suppression
2012
The Neutrophil Life Cycle
2019
Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
2018 Standout
Synergistic induction of apoptosis in high-risk DLBCL by BCL2 inhibition with ABT-199 combined with pharmacologic loss of MCL1
2015
Targeting the B-cell receptor signaling pathway in B lymphoid malignancies
2014
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Cellular senescence: from physiology to pathology
2014 Standout
Deacetylated sialic acids modulates immune mediated cytotoxicity via the sialic acid-Siglec pathway
2021 StandoutNobel
Metformin inhibits the senescence‐associated secretory phenotype by interfering with IKK /NF ‐κB activation
2013
Regulatory T Cells and Human Disease
2020 StandoutNobel
Aging, Cellular Senescence, and Cancer
2012 Standout
Paracaspase MALT1 Deficiency Protects Mice from Autoimmune-Mediated Demyelination
2013
NF-κB pathways in hematological malignancies
2014
IKKα inactivation promotes Kras-initiated lung adenocarcinoma development through disrupting major redox regulatory pathways
2018
DAMP-sensing receptors in sterile inflammation and inflammatory diseases
2019 Standout
The innate immune sensor Toll-like receptor 2 controls the senescence-associated secretory phenotype
2019
Diffuse large B-cell lymphoma: optimizing outcome in the context of clinical and biologic heterogeneity
2014
STAT3 and STAT5 Activation in Solid Cancers
2019
cGAS is essential for cellular senescence
2017
Cellular senescence links aging and diabetes in cardiovascular disease
2018
Inflammatory responses and inflammation-associated diseases in organs
2017 Standout
Roles of NF-κB in Cancer and Inflammatory Diseases and Their Therapeutic Approaches
2016 Standout
Flavonoids in Cancer and Apoptosis
2018 Standout
Lenalidomide efficacy in activated B ‐cell‐like subtype diffuse large B ‐cell lymphoma is dependent upon IRF 4 and cereblon expression
2012
Works of Michael Grau being referenced
Splenic Marginal Zone Granulocytes Acquire an Accentuated Neutrophil B-Cell Helper Phenotype in Chronic Lymphocytic Leukemia
2016
Malt1-dependent RelB cleavage promotes canonical NF-κB activation in lymphocytes and lymphoma cell lines
2011
Opposing roles of NF-κB in anti-cancer treatment outcome unveiled by cross-species investigations
2011
Pharmacologic Inhibition of MALT1 Protease by Phenothiazines as a Therapeutic Approach for the Treatment of Aggressive ABC-DLBCL
2012
MCL1 is deregulated in subgroups of diffuse large B-cell lymphoma
2012
Oncogenic CARMA1 couples NF-κB and β-catenin signaling in diffuse large B-cell lymphomas
2016
PTEN loss defines a PI3K/AKT pathway-dependent germinal center subtype of diffuse large B-cell lymphoma
2013
IκB-ζ controls the constitutive NF-κB target gene network and survival of ABC DLBCL
2013
CARMA1- and MyD88-dependent activation of Jun/ATF-type AP-1 complexes is a hallmark of ABC diffuse large B-cell lymphomas
2016
Critical role of PI3K signaling for NF-κB–dependent survival in a subset of activated B-cell–like diffuse large B-cell lymphoma cells
2010